HAE
HAEMONETICS CORP
NYSE · Healthcare · Medical - Instruments & Supplies · US
$108.42
+0.76%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $1.30
- Revenue estimate
- $344.3M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $1.14
- EPS estimate
- $1.08
- Revenue actual
- $339.4M
- Revenue estimate
- $327.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +5.5%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $110
- PT range
- $86 – $125
- Analysts
- 7
6 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $1.08 | $1.14 | Beat 5.36% | $339.4M |
| May 7, 2026 | $1.28 | $1.29 | Beat 0.55% | $346.4M |
| Feb 5, 2026 | $1.27 | $1.31 | Beat 2.91% | $339.0M |
| Nov 6, 2025 | $1.12 | $1.27 | Beat 12.99% | $327.3M |
| Aug 7, 2025 | $1.01 | $1.10 | Beat 8.91% | $321.4M |
| May 8, 2025 | $1.22 | $1.24 | Beat 1.64% | $330.6M |
| Feb 6, 2025 | $1.18 | $1.19 | Beat 0.85% | $348.5M |
| Nov 7, 2024 | $1.09 | $1.12 | Beat 2.75% | $345.5M |
| Aug 8, 2024 | $1.03 | $1.02 | Miss -0.97% | $336.2M |
| May 9, 2024 | $0.88 | $0.90 | Beat 2.27% | $343.3M |
| Feb 8, 2024 | $0.97 | $1.04 | Beat 7.22% | $336.3M |
| Nov 2, 2023 | $0.94 | $0.99 | Beat 5.32% | $318.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026